oncosis

oncosis

 [ong-ko´sis]
a morbid condition marked by the development of tumors.

on·co·sis

(ong-kō'sis),
A condition characterized by the formation of one or more neoplasms or tumors.
[G. onkōsis, swelling, fr. onkos, bulk, mass]

oncosis

/on·co·sis/ (ong-ko´sis) a morbid condition marked by the development of tumors.

oncosis

An obsolete term for:
(1) Ischaemic cell death;
(2) Oncogenesis; 
(3) A nonspecific term for the presence of multiple masses, regardless of cause (inflammatory or neoplastic) or portent (benign or malignant).

on·co·sis

(ong-kō'sis)
The formation of one or more neoplasms or tumors.
[G. onkōsis, swelling, fr. onkos, bulk, mass]

oncosis

a morbid condition marked by the development of tumors.
Mentioned in ?
References in periodicals archive ?
Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage.
Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells, Exp.
Majino G, Jorris I, 1995, Apoptosis, oncosis, and necrosis.
Morphological and biochemical aspects of apoptosis, oncosis and necrosis.
Oncosis refers to any cell death characterized by marked cell swelling.
Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation.
Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: A reconsideration of the specificity of the annexin V/propidium iodide assay.
Oncosis in MA104 cells is induced by rotavirus infection through an increase in intracellular [Ca.
The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo.
3) Ultrastructural studies have indicated that the observed necrotic processes are a combination of apoptosis (active/ programmed cell death) and oncosis (passive/accidental cell death).
Oncosis spun-off a new company, Cyntellect, to develop and commercialize the LEAP technology platform, which provides both high-throughput, multi-parameter cellular analysis as well as laser-based cellular manipulation .